David-Alexandre C. Gros
Overview
David-Alexandre C. Gros received an average of $4M in total compensation, including $327K in salary, at Tokai Pharmaceuticals between 2020 and 2021. David-Alexandre Gros also received an average of $4M at Alnylam Pharmaceuticals from 2015 to 2017.
- 2021
- 2020
- 2017
- 2016
- 2015
Tokai PharmaceuticalsChief Executive Officer
Tokai PharmaceuticalsChief Executive Officer
Alnylam PharmaceuticalsFormer Senior Vice President, Chief Business Officer former principal financial officer
Alnylam PharmaceuticalsFormer Senior Vice President, Chief Business Officer former principal financial officer
Alnylam PharmaceuticalsSenior Vice President, Chief Business Officer
Source: SEC filings on April 28, 2022, March 23, 2018, and March 17, 2016.
Related executives
We found 24 more executives who work or worked at Tokai Pharmaceuticals and Alnylam Pharmaceuticals.
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
Paul Little
Tokai Pharmaceuticals
Chief Financial Officer
Bryan Smith
Tokai Pharmaceuticals
General Counsel
Barry Greene
Alnylam Pharmaceuticals